C84.38 Lymphoepithelioid lymphoma, lymph nodes of multiple sites

Name of the Condition

• Lymphoepithelioid lymphoma, lymph nodes of multiple sites (ICD-10 Code: C84.38)

Summary

Lymphoepithelioid lymphoma, lymph nodes of multiple sites, is a rare subtype of mature T-cell lymphoma characterized by a distinctive histological pattern of epithelioid histiocytes and small lymphocytes. It typically presents as generalized lymphadenopathy involving multiple lymph node regions and may involve extranodal sites. The condition is part of the broader category of peripheral T-cell lymphomas and is distinguished by its unique cellular composition, though its clinical behavior can vary.

Causes

The exact cause of lymphoepithelioid lymphoma is not fully understood. It is believed to involve genetic alterations in T-lymphocytes, leading to abnormal proliferation and tissue infiltration. Chronic antigen stimulation or immune dysregulation may contribute to its development, though specific triggers remain unclear. No consistent association with viral infections has been established.

Risk Factors

• Age: More common in adults, particularly those over 50.
• Immunosuppression: Conditions or treatments that weaken the immune system may increase risk.
• Genetic predisposition: Family history of lymphoma or related disorders.
• Ethnicity: Some studies suggest higher prevalence in certain populations, though data is limited.

Symptoms

• Painless swelling of lymph nodes (lymphadenopathy) in multiple regions.
• Fatigue or unexplained weight loss.
• Fever or night sweats (less common).
• Possible involvement of extranodal sites (e.g., skin, spleen).

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies (e.g., CT or PET scans) to assess lymph node involvement, and histopathological examination of biopsy tissue. Immunohistochemistry and molecular testing may be used to confirm the T-cell origin and rule out other lymphomas. Staging helps determine the extent of disease.

Treatment Options

Treatment depends on disease stage and patient factors. Options may include chemotherapy, immunotherapy, or radiation therapy. Clinical trials or targeted therapies may be considered for advanced cases. Multidisciplinary care with hematologists and oncologists is typical.

Prognosis and Follow-Up

Prognosis varies based on disease extent and response to treatment. Regular follow-up with imaging and clinical assessments is essential to monitor for recurrence or progression. Long-term surveillance is recommended due to the risk of relapse.

Complications

• Disease progression or transformation to a more aggressive lymphoma.
• Infection risk due to immunosuppression from treatment.
• Organ dysfunction if extranodal sites are involved.

Lifestyle & Prevention

• Maintain a healthy immune system through balanced nutrition and regular exercise.
• Avoid known immunosuppressive exposures (e.g., unnecessary medications).
• Follow recommended cancer screening guidelines for early detection.

When to Seek Professional Help

Seek medical attention for persistent, unexplained lymph node swelling, unexplained weight loss, or systemic symptoms like fever. Prompt evaluation is important for early diagnosis and management.

Tips for Medical Coders

Code C84.38 is specific to lymphoepithelioid lymphoma involving lymph nodes of multiple sites. Documentation should specify the anatomical regions involved and confirm the histological subtype. Ensure alignment with ICD-10-CM guidelines for lymphoma coding, including proper staging and site specificity.